Exact Mass: 495.2158
Exact Mass Matches: 495.2158
Found 301 metabolites which its exact mass value is equals to given mass value 495.2158
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
GW 1929
GW 1929 is an orally active peroxisome proliferator-activated receptor-γ (PPARγ) agonist with a pKi of 8.84 for human PPAR-γ, and pEC50s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ, respectively. GW 1929 (hydrochloride) has antidiabetic efficacy and neuroprotective potential[1][2].
19-Benzyl-7-hydroxy-7,9,16,17-tetramethyl-2,4,15-trioxa-20-azatetracyclo[11.8.0.01,18.014,16]henicosa-5,11-diene-3,8,21-trione
2-(2-Benzoylanilino)-3-[4-[2-[methyl(2-pyridinyl)amino]ethoxy]phenyl]propanoic acid
WYE-354
WYE-354 is an ATP-competitive mTOR inhibitor with an IC50 of 5 nM. WYE-354 also inhibits PI3Kα and PI3Kγ with IC50s of 1.89 μM and 7.37 μM, respectively. WYE-354 inhibits both mTORC1 and mTORC2. WYE-354 induces autophagy activation in vitro[3]. WYE-354 is an ATP-competitive mTOR inhibitor with an IC50 of 5 nM. WYE-354 also inhibits PI3Kα and PI3Kγ with IC50s of 1.89 μM and 7.37 μM, respectively. WYE-354 inhibits both mTORC1 and mTORC2. WYE-354 induces autophagy activation in vitro[3].
Cytochalasin E
D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D006133 - Growth Substances > D006131 - Growth Inhibitors A natural product found in Arthrinium sacchari.
Ala Phe Met Gln
Ala Phe Gln Met
Ala Gly Trp Tyr
Ala Gly Tyr Trp
Ala Met Phe Gln
Ala Met Gln Phe
Ala Gln Phe Met
Ala Gln Met Phe
Ala Trp Gly Tyr
Ala Trp Tyr Gly
Ala Tyr Gly Trp
Ala Tyr Trp Gly
Cys Phe Ile Asn
Cys Phe Leu Asn
Cys Phe Asn Ile
Cys Phe Asn Leu
Cys Phe Gln Val
Cys Phe Val Gln
Cys Ile Phe Asn
Cys Ile Asn Phe
Cys Leu Phe Asn
Cys Leu Asn Phe
Cys Asn Phe Ile
Cys Asn Phe Leu
Cys Asn Ile Phe
Cys Asn Leu Phe
Cys Gln Phe Val
Cys Gln Val Phe
Cys Val Phe Gln
Cys Val Gln Phe
Asp His Pro Gln
Asp His Gln Pro
Asp Pro His Gln
Asp Pro Gln His
Asp Gln His Pro
Asp Gln Pro His
Glu His Asn Pro
Glu His Pro Asn
Glu Asn His Pro
Glu Asn Pro His
Glu Pro His Asn
Glu Pro Asn His
Phe Ala Met Gln
Phe Ala Gln Met
Phe Cys Ile Asn
Phe Cys Leu Asn
Phe Cys Asn Ile
Phe Cys Asn Leu
Phe Cys Gln Val
Phe Cys Val Gln
Phe Gly Ser Trp
Phe Gly Trp Ser
Phe Ile Cys Asn
Phe Ile Asn Cys
Phe Leu Cys Asn
Phe Leu Asn Cys
Phe Met Ala Gln
Phe Met Gln Ala
Phe Asn Cys Ile
Phe Asn Cys Leu
Phe Asn Ile Cys
Phe Asn Leu Cys
Phe Gln Ala Met
Phe Gln Cys Val
Phe Gln Met Ala
Phe Gln Val Cys
Phe Ser Gly Trp
Phe Ser Trp Gly
Phe Val Cys Gln
Phe Val Gln Cys
Phe Trp Gly Ser
Phe Trp Ser Gly
Gly Ala Trp Tyr
Gly Ala Tyr Trp
Gly Phe Ser Trp
Gly Phe Trp Ser
Gly His Pro Trp
Gly His Trp Pro
Gly Pro His Trp
Gly Pro Trp His
Gly Ser Phe Trp
Gly Ser Trp Phe
Gly Trp Ala Tyr
Gly Trp Phe Ser
Gly Trp His Pro
Gly Trp Pro His
Gly Trp Ser Phe
Gly Trp Tyr Ala
Gly Tyr Ala Trp
Gly Tyr Trp Ala
His Asp Pro Gln
His Asp Gln Pro
His Glu Asn Pro
His Glu Pro Asn
His Gly Pro Trp
His Gly Trp Pro
His Asn Glu Pro
His Asn Pro Glu
His Pro Asp Gln
His Pro Glu Asn
His Pro Gly Trp
His Pro Asn Glu
His Pro Gln Asp
His Pro Trp Gly
His Gln Asp Pro
His Gln Pro Asp
His Trp Gly Pro
His Trp Pro Gly
Ile Cys Phe Asn
Ile Cys Asn Phe
Ile Phe Cys Asn
Ile Phe Asn Cys
Ile Asn Cys Phe
Ile Asn Phe Cys
Lys Met Met Ser
Lys Met Ser Met
Lys Ser Met Met
Leu Cys Phe Asn
Leu Cys Asn Phe
Leu Phe Cys Asn
Leu Phe Asn Cys
Leu Asn Cys Phe
Leu Asn Phe Cys
Met Ala Phe Gln
Met Ala Gln Phe
Met Phe Ala Gln
Met Phe Gln Ala
Met Lys Met Ser
Met Lys Ser Met
Met Met Lys Ser
Met Met Ser Lys
Met Gln Ala Phe
Met Gln Phe Ala
Met Ser Lys Met
Met Ser Met Lys
Asn Cys Phe Ile
Asn Cys Phe Leu
Asn Cys Ile Phe
Asn Cys Leu Phe
Asn Glu His Pro
Asn Glu Pro His
Asn Phe Cys Ile
Asn Phe Cys Leu
Asn Phe Ile Cys
Asn Phe Leu Cys
Asn His Glu Pro
Asn His Pro Glu
Asn Ile Cys Phe
Asn Ile Phe Cys
Asn Leu Cys Phe
Asn Leu Phe Cys
Asn Pro Glu His
Asn Pro His Glu
Pro Asp His Gln
Pro Asp Gln His
Pro Glu His Asn
Pro Glu Asn His
Pro Gly His Trp
Pro Gly Trp His
Pro His Asp Gln
Pro His Glu Asn
Pro His Gly Trp
Pro His Asn Glu
Pro His Gln Asp
Pro His Trp Gly
Pro Asn Glu His
Pro Asn His Glu
Pro Gln Asp His
Pro Gln His Asp
Pro Trp Gly His
Pro Trp His Gly
Gln Ala Phe Met
Gln Ala Met Phe
Gln Cys Phe Val
Gln Cys Val Phe
Gln Asp His Pro
Gln Asp Pro His
Gln Phe Ala Met
Gln Phe Cys Val
Gln Phe Met Ala
Gln Phe Val Cys
Gln His Asp Pro
Gln His Pro Asp
Gln Met Ala Phe
Gln Met Phe Ala
Gln Pro Asp His
Gln Pro His Asp
Gln Val Cys Phe
Gln Val Phe Cys
Ser Phe Gly Trp
Ser Phe Trp Gly
Ser Gly Phe Trp
Ser Gly Trp Phe
Ser Lys Met Met
Ser Met Lys Met
Ser Met Met Lys
Ser Trp Phe Gly
Ser Trp Gly Phe
Val Cys Phe Gln
Val Cys Gln Phe
Val Phe Cys Gln
Val Phe Gln Cys
Val Gln Cys Phe
Val Gln Phe Cys
Trp Ala Gly Tyr
Trp Ala Tyr Gly
Trp Phe Gly Ser
Trp Phe Ser Gly
Trp Gly Ala Tyr
Trp Gly Phe Ser
Trp Gly His Pro
Trp Gly Pro His
Trp Gly Ser Phe
Trp Gly Tyr Ala
Trp His Gly Pro
Trp His Pro Gly
Trp Pro Gly His
Trp Pro His Gly
Trp Ser Phe Gly
Trp Ser Gly Phe
Trp Tyr Ala Gly
Trp Tyr Gly Ala
Tyr Ala Gly Trp
Tyr Ala Trp Gly
Tyr Gly Ala Trp
Tyr Gly Trp Ala
Tyr Trp Ala Gly
Tyr Trp Gly Ala
benzene,9-[fluoren-9-ylidene(phenyl)methyl]fluorene
GW1929
GW 1929 is an orally active peroxisome proliferator-activated receptor-γ (PPARγ) agonist with a pKi of 8.84 for human PPAR-γ, and pEC50s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ, respectively. GW 1929 (hydrochloride) has antidiabetic efficacy and neuroprotective potential[1][2].